Reply letter to: pitfalls and limitations of a single-centre, retrospectively derived prognostic score for phase I oncology trial participant - reply to Füssenich et al.: a new, simple and objective prognostic score for phase I cancer patients
Eur J Cancer
.
2012 Mar;48(4):597-8.
doi: 10.1016/j.ejca.2012.01.020.
Authors
C M L van Herpen
,
S Teerenstra
,
I M E Desar
,
W T A van der Graaf
PMID:
22338604
DOI:
10.1016/j.ejca.2012.01.020
No abstract available
Publication types
Letter
Comment
MeSH terms
Clinical Trials, Phase I as Topic / methods*
Female
Humans
Male
Medical Oncology / standards*